Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Pivotal Phase 2 Trial for NSCLC ?

<< Previous

Bullboard Posts

Next >>

Comment by stocksnbonds458on May 11, 2022 12:14pm

260 Views

Post# 34674310

RE:RE:RE:RE:RE:Pivotal Phase 2 Trial for NSCLC ?

Could you imagine how much of a monster TLT would be if their drug is as effective on NSCLC as it is on Bladder cancer? Lung cancer is responsible for 23% of all cancer deaths in the US, 83% of those deaths were diagnosed with NSCLC. What a miracle it would be, so may lives would be saved!

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments